Journal profile · Endocrinology & Metabolism
Diabetes
ISSN 0012-1797 · eISSN 1939-327X · American Diabetes Association Inc. · UNITED STATES · Monthly · Founded 1952
Diabetes: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 7.8; subscription journal; median 152 days to acceptance (91 articles, last 24 months); community-reported acceptance: about 37.5%; 2,474 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetes is published by American Diabetes Association Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Pancreatic function and diabetes, Diabetes Management and Research and Diabetes and associated disorders, together about 37.4% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
Source: LetPub
Research area (LetPub): Endocrinology & Metabolism
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pancreatic function and diabetesMedicine15.3%
- Diabetes Management and ResearchMedicine12%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology10.1%
- Diabetes Treatment and ManagementMedicine9.6%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology8.5%
- Adipose Tissue and MetabolismMedicine6.2%
- Diet and metabolism studiesMedicine4.8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.8LetPub ·
- CiteScore 2026-06
- 10.8LetPub ·
- SJR 2026-06
- 2.61LetPub ·
- SNIP 2026-06
- 1.46LetPub ·
- h-index
- 304LetPub ·
- h-index
- 450OpenAlex ·
- i10-index
- 18,849OpenAlex ·
- 2-year mean citedness
- 0.6OpenAlex ·
- Self-citation rate
- 2.2%LetPub ·
- Share of gold OA articles
- 2.49%LetPub ·
Volume
- Articles per year
- 198LetPub ·
Articles by year OpenAlex count · 45,517 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 2,322 | 111 | 117 |
| 2025 | 2,474 | 188 | 1,334 |
| 2024 | 2,313 | 189 | 2,817 |
| 2023 | 2,298 | 193 | 3,807 |
| 2022 | 2,012 | 238 | 6,987 |
| 2021 | 1,751 | 230 | 7,992 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
152 daysMedian, submission to acceptance · P25–P75 106 days – 230 days
- Acceptance to online
- median 27 days (41 articles)
- Submission to online
- median 194 days
- Sample
- 91 articles with submission and acceptance dates (505 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 37.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Diabetes Association Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1952
- ISSN
- 0012-1797
- Electronic ISSN
- 1939-327X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Diabetes
What CAS zone is Diabetes in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetes is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetes?
The latest impact factor listed by LetPub is 7.8; CiteScore 10.8, h-index 450.
How long does peer review take at Diabetes?
Based on the dates recorded on 91 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 152 days (interquartile range 106–230 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 37.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Diabetes?
According to LetPub and DOAJ records, Diabetes is indexed in SCIE and Scopus.
Is Diabetes open access, and what is the APC?
Diabetes is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .